Skip to content

Application of fractional carbon dioxide laser in improving localized scleroderma skin lesions

Application of fractional carbon dioxide laser in improving localized scleroderma skin lesions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065939
Enrollment
Unknown
Registered
2022-11-18
Start date
2022-11-25
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Localized scleroderma

Interventions

Intervention group:fractional carbon dioxide laser

Sponsors

The Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients (male or female) have a clinical diagnosis of localized scleroderma by two attending dermatologists; 2. Patients are either new or discontinued systemic treatment for localized scleroderma for at least three months.

Exclusion criteria

Exclusion criteria: 1. Non-consent to participate in research during the informed consent process; 2. Suffering from photosensitive diseases or using medications that increase photosensitivity; 3. Patients ongoing or have a history of serious illness(coronary heart disease, pulmonary embolism, cerebrovascular accident, etc.); 4. Active cutaneous bacterial skin infections or herpes simplex (cold sores) in the area to be treated; 5. Pregnancy, planned pregnancy, or lactation patients; 6. Patients with a tendency to form keloid and hypertrophic scars.

Design outcomes

Primary

MeasureTime frame
Modified localized scleroderma skin severity index;Cutaneous induration;Visual analogue scale;Ultrasonophy;Skin biopsy;

Countries

China

Contacts

Public ContactXiao Rong

The Second Xiangya Hospital of Central South University

xiaorong65@aliyun.com+86 13808425555

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026